Purpose Life Sciences: Partnering
on Complex Platform Trials

“In a world where change is the only constant, we believe Veeva is going to bring more tools that will allow us even more real-time behavior and insights that will affect the way we are conducting the study and reporting upstream.”

- Michael Zimmerman, CTO, Purpose Life Sciences

Agile design is key to supporting complex trials with ongoing changes, protocol amendments, and multiple drugs. As a company supporting large-scale COVID studies, Purpose Life Sciences is uniquely aware of the benefits of utilizing Veeva EDC.